Search clinical trials for: SEROQUEL (quetiapine fumarate) Tablets

Total 459 results

AstraZeneca

Terminated

Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy (RELEASE)

Acute Bipolar Mania

Korea, Republic of
AstraZeneca

Completed

Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia (eXtRa)

Schizophrenia

Italy, Germany, Austria, Spain, Denmark
AstraZeneca

Completed

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

Bipolar Disorder | Depression, Bipolar

United States
Guangzhou Mental Hospital
First Affiliated Hospital of Jinan University; Second Affiliated Hospital of... and other collaborators

Unknown

A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder

Bipolar Disorder

China
AstraZeneca

Completed

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder (UNIQUE)

Major Depressive Disorder

Belgium
AstraZeneca

Terminated

Seroquel XR in Adults With Schizophrenia

Schizophrenia

Thailand
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition

Fasting State

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

Fed

India
University of Texas Southwestern Medical Center

Completed

Quetiapine for Bipolar Disorder and Alcohol Dependence

Alcohol Dependence | Bipolar Disorder

United States
Severance Hospital

Unknown

Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) (ES-ARMS)

Schizophrenia | Abnormal Mental State

Korea, Republic of
BC Women's Hospital & Health Centre

Completed

Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II

Postpartum Depression

Canada
Sunnybrook Health Sciences Centre
AstraZeneca

Completed

Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder

Depressive Disorder, Major

Canada
AstraZeneca

Completed

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

Bipolar Depression
AstraZeneca

Completed

Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder (ANCHOR 150)

Schizophrenia | Bipolar I Disorder

United States, Russian Federation, Philippines, Malaysia, South Africa, Poland, Serbia, Ukraine, India
AstraZeneca

Completed

Quetiapine Fumarate Bipolar Maintenance Monotherapy (SPaRCLe)

Bipolar Disorder

United States, Bulgaria, Peru, Russian Federation, Philippines, Malaysia, Lithuania, Romania, Ukraine, Argentina, Taiwan, Mexico, Thailand, India, Colombia
AstraZeneca

Completed

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Schizophrenia

Malaysia
Mayo Clinic

Completed

Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine

Delirium | Dementia

United States
Indiana University School of Medicine
AstraZeneca

Completed

Brain Imaging of Quetiapine Response in Anxious Depression

Major Depression

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition

Healthy

India
AstraZeneca

Completed

Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder

Post-Traumatic Stress Disorder

Australia
AstraZeneca

Completed

Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic

Schizophrenia

China
University Hospitals Cleveland Medical Center
National Alliance for Research on Schizophrenia and Depression; AstraZeneca

Completed

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

Anxiety Disorders | Anxiety | Bipolar Disorder | Substance Use Disorders

United States
AstraZeneca

Completed

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Mania | Manic Disorder | Manic State | Affective Psychosis, Bipolar | Manic-Depressive Psychosis | Psychoses, Manic-Depressive

United States
University of Regensburg
AstraZeneca

Completed

Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients

Schizophrenia

Germany
AstraZeneca

Completed

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders (OPAL)

Major Depressive Disorder

United States
AstraZeneca

Completed

Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) (QUENCH)

Schizophrenia

Korea, Republic of
AstraZeneca

Completed

Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients

Borderline Personality Disorder

Netherlands
AstraZeneca

Completed

Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression

Bipolar Depression

China
AstraZeneca

Completed

Generalized Anxiety Disorder Adjunct Study

Anxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety States

United States
AstraZeneca

Completed

Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients

Schizophrenia

China
Inje University

Unknown

The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope

Major Depressive Disorder

Korea, Republic of
Dr Alexander McIntyre Inc.

Completed

A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety

Major Depression With Comorbid Anxiety Symptoms

Canada
Otsuka Pharmaceutical Development & Commercialization...
PRA Health Sciences

Completed

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder

United States
University of Erlangen-Nürnberg Medical School
AstraZeneca

Completed

Quetiapine and the Dopaminergic Epigenetic Control

Schizophrenia

Germany
AstraZeneca

Completed

Phase III/Seroquel SR Bipolar Depression Monotherapy - US

Depression, Bipolar | Affective Psychosis, Bipolar | Manic-Depressive Psychosis | Psychoses, Manic-Depressive

United States
University of Calgary
Multiple Sclerosis Society of Canada

Completed

Safety and Tolerability of Quetiapine in Multiple Sclerosis

Multiple Sclerosis

Canada
AstraZeneca
Quintiles, Inc.

Completed

Adult Bipolar Mania

Acute Mania

Bulgaria, Poland, Russian Federation, South Africa, Germany, Ukraine, Israel, India, Belgium
Dr Alexander McIntyre Inc.

Completed

A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome

Major Depression

Canada
AstraZeneca

Completed

Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia (SCORE)

Schizophrenia

Sweden
National Institute on Alcohol Abuse and Alcoholism...
National Institute on Drug Abuse (NIDA); AstraZeneca; US Department of Veterans...

Completed

Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency

Alcoholism | Alcohol Abuse

United States
Indiana University
AstraZeneca

Completed

A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients

Panic Disorder

United States
AstraZeneca

Completed

Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia (SPECTRUM)

Schizophrenia

Canada, Australia, Korea, Republic of, Hong Kong
Cambridge Health Alliance

Completed

Post-Traumatic Stress Disorder (PTSD) and Seroquel

Post-Traumatic Stress Disorder

United States
University of Tennessee Graduate School of Medicine

Completed

Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients

Psychomotor Agitation

United States
AstraZeneca

Completed

Seroquel on Glucose Metabolism

Schizophrenia

Bulgaria, Czech Republic, South Africa, United Kingdom, Germany, Hungary, Romania, Slovakia, Norway
AstraZeneca

Completed

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Schizophrenia

Bulgaria, Poland
Ain Shams University

Recruiting

Quetiapine as Prophylaxis for Delirium in CABG

Delirium

Egypt
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Quetiapine Treatment for Cannabis Dependence (STUC)

Cannabis Dependence

United States
University of Cincinnati
AstraZeneca

Completed

A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents

Mood Disorders

United States
AstraZeneca

Terminated

Quetiapine in Postpartum Depression

Postpartum Depressive Disorder

Germany

Search clinical trials for: SEROQUEL (quetiapine fumarate) Tablets

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations